0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Infection and Infection POCT Testing Market Research Report 2024
Published Date: August 2024
|
Report Code: QYRE-Auto-33W17891
Home | Market Reports | Health| Health Conditions| Infectious Diseases
Global Infection and Infection POCT Testing Market Research Report 2024
BUY CHAPTERS

Global Infection and Infection POCT Testing Market Research Report 2024

Code: QYRE-Auto-33W17891
Report
August 2024
Pages:99
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Infection and Infection POCT Testing Market

Infectious and infectious POCT (Point-of-Care Testing) tests are rapid diagnostic tests performed at the point of patient care. POCT testing devices and kits are designed to provide test results quickly without the need for complex laboratory facilities, usually within minutes to hours. This is critical for rapid diagnosis and timely treatment of infectious diseases and infections.
The global Infection and Infection POCT Testing market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for Infection and Infection POCT Testing is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Infection and Infection POCT Testing is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Infection and Infection POCT Testing in Hospital is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Infection and Infection POCT Testing include SERION Immunologics, SD BIOSENSOR, Bio-Rad Laboratories, Thermo Fisher Scientific, Abbott Laboratories, Roche Diagnostics, BioMerieux, PerkinElmer, Enzo Life Sciences, Abcam, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Infection and Infection POCT Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Infection and Infection POCT Testing.
The Infection and Infection POCT Testing market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Infection and Infection POCT Testing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Infection and Infection POCT Testing companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Infection and Infection POCT Testing Market Report

Report Metric Details
Report Name Infection and Infection POCT Testing Market
Segment by Type
Segment by Application
  • Hospital
  • Clinic
  • Other
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company SERION Immunologics, SD BIOSENSOR, Bio-Rad Laboratories, Thermo Fisher Scientific, Abbott Laboratories, Roche Diagnostics, BioMerieux, PerkinElmer, Enzo Life Sciences, Abcam, DRG International, Creative Diagnostics, Beyotime, GenScript, Kehua Biotech, Mindray Medical, Antu Biotech, BD, Siemens, Qiagen
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Infection and Infection POCT Testing company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Infection and Infection POCT Testing Market report?

Ans: The main players in the Infection and Infection POCT Testing Market are SERION Immunologics, SD BIOSENSOR, Bio-Rad Laboratories, Thermo Fisher Scientific, Abbott Laboratories, Roche Diagnostics, BioMerieux, PerkinElmer, Enzo Life Sciences, Abcam, DRG International, Creative Diagnostics, Beyotime, GenScript, Kehua Biotech, Mindray Medical, Antu Biotech, BD, Siemens, Qiagen

What are the Application segmentation covered in the Infection and Infection POCT Testing Market report?

Ans: The Applications covered in the Infection and Infection POCT Testing Market report are Hospital, Clinic, Other

What are the Type segmentation covered in the Infection and Infection POCT Testing Market report?

Ans: The Types covered in the Infection and Infection POCT Testing Market report are Equipment, Test Kit, Other

Recommended Reports

Infectious Disease POCT

General POCT Devices

Rapid Diagnostic Kits

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Infection and Infection POCT Testing Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Equipment
1.2.3 Test Kit
1.2.4 Other
1.3 Market by Application
1.3.1 Global Infection and Infection POCT Testing Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Infection and Infection POCT Testing Market Perspective (2019-2030)
2.2 Global Infection and Infection POCT Testing Growth Trends by Region
2.2.1 Global Infection and Infection POCT Testing Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Infection and Infection POCT Testing Historic Market Size by Region (2019-2024)
2.2.3 Infection and Infection POCT Testing Forecasted Market Size by Region (2025-2030)
2.3 Infection and Infection POCT Testing Market Dynamics
2.3.1 Infection and Infection POCT Testing Industry Trends
2.3.2 Infection and Infection POCT Testing Market Drivers
2.3.3 Infection and Infection POCT Testing Market Challenges
2.3.4 Infection and Infection POCT Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Infection and Infection POCT Testing Players by Revenue
3.1.1 Global Top Infection and Infection POCT Testing Players by Revenue (2019-2024)
3.1.2 Global Infection and Infection POCT Testing Revenue Market Share by Players (2019-2024)
3.2 Global Infection and Infection POCT Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Infection and Infection POCT Testing Revenue
3.4 Global Infection and Infection POCT Testing Market Concentration Ratio
3.4.1 Global Infection and Infection POCT Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Infection and Infection POCT Testing Revenue in 2023
3.5 Global Key Players of Infection and Infection POCT Testing Head office and Area Served
3.6 Global Key Players of Infection and Infection POCT Testing, Product and Application
3.7 Global Key Players of Infection and Infection POCT Testing, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Infection and Infection POCT Testing Breakdown Data by Type
4.1 Global Infection and Infection POCT Testing Historic Market Size by Type (2019-2024)
4.2 Global Infection and Infection POCT Testing Forecasted Market Size by Type (2025-2030)
5 Infection and Infection POCT Testing Breakdown Data by Application
5.1 Global Infection and Infection POCT Testing Historic Market Size by Application (2019-2024)
5.2 Global Infection and Infection POCT Testing Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Infection and Infection POCT Testing Market Size (2019-2030)
6.2 North America Infection and Infection POCT Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Infection and Infection POCT Testing Market Size by Country (2019-2024)
6.4 North America Infection and Infection POCT Testing Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Infection and Infection POCT Testing Market Size (2019-2030)
7.2 Europe Infection and Infection POCT Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Infection and Infection POCT Testing Market Size by Country (2019-2024)
7.4 Europe Infection and Infection POCT Testing Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Infection and Infection POCT Testing Market Size (2019-2030)
8.2 Asia-Pacific Infection and Infection POCT Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Infection and Infection POCT Testing Market Size by Region (2019-2024)
8.4 Asia-Pacific Infection and Infection POCT Testing Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Infection and Infection POCT Testing Market Size (2019-2030)
9.2 Latin America Infection and Infection POCT Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Infection and Infection POCT Testing Market Size by Country (2019-2024)
9.4 Latin America Infection and Infection POCT Testing Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Infection and Infection POCT Testing Market Size (2019-2030)
10.2 Middle East & Africa Infection and Infection POCT Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Infection and Infection POCT Testing Market Size by Country (2019-2024)
10.4 Middle East & Africa Infection and Infection POCT Testing Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 SERION Immunologics
11.1.1 SERION Immunologics Company Details
11.1.2 SERION Immunologics Business Overview
11.1.3 SERION Immunologics Infection and Infection POCT Testing Introduction
11.1.4 SERION Immunologics Revenue in Infection and Infection POCT Testing Business (2019-2024)
11.1.5 SERION Immunologics Recent Development
11.2 SD BIOSENSOR
11.2.1 SD BIOSENSOR Company Details
11.2.2 SD BIOSENSOR Business Overview
11.2.3 SD BIOSENSOR Infection and Infection POCT Testing Introduction
11.2.4 SD BIOSENSOR Revenue in Infection and Infection POCT Testing Business (2019-2024)
11.2.5 SD BIOSENSOR Recent Development
11.3 Bio-Rad Laboratories
11.3.1 Bio-Rad Laboratories Company Details
11.3.2 Bio-Rad Laboratories Business Overview
11.3.3 Bio-Rad Laboratories Infection and Infection POCT Testing Introduction
11.3.4 Bio-Rad Laboratories Revenue in Infection and Infection POCT Testing Business (2019-2024)
11.3.5 Bio-Rad Laboratories Recent Development
11.4 Thermo Fisher Scientific
11.4.1 Thermo Fisher Scientific Company Details
11.4.2 Thermo Fisher Scientific Business Overview
11.4.3 Thermo Fisher Scientific Infection and Infection POCT Testing Introduction
11.4.4 Thermo Fisher Scientific Revenue in Infection and Infection POCT Testing Business (2019-2024)
11.4.5 Thermo Fisher Scientific Recent Development
11.5 Abbott Laboratories
11.5.1 Abbott Laboratories Company Details
11.5.2 Abbott Laboratories Business Overview
11.5.3 Abbott Laboratories Infection and Infection POCT Testing Introduction
11.5.4 Abbott Laboratories Revenue in Infection and Infection POCT Testing Business (2019-2024)
11.5.5 Abbott Laboratories Recent Development
11.6 Roche Diagnostics
11.6.1 Roche Diagnostics Company Details
11.6.2 Roche Diagnostics Business Overview
11.6.3 Roche Diagnostics Infection and Infection POCT Testing Introduction
11.6.4 Roche Diagnostics Revenue in Infection and Infection POCT Testing Business (2019-2024)
11.6.5 Roche Diagnostics Recent Development
11.7 BioMerieux
11.7.1 BioMerieux Company Details
11.7.2 BioMerieux Business Overview
11.7.3 BioMerieux Infection and Infection POCT Testing Introduction
11.7.4 BioMerieux Revenue in Infection and Infection POCT Testing Business (2019-2024)
11.7.5 BioMerieux Recent Development
11.8 PerkinElmer
11.8.1 PerkinElmer Company Details
11.8.2 PerkinElmer Business Overview
11.8.3 PerkinElmer Infection and Infection POCT Testing Introduction
11.8.4 PerkinElmer Revenue in Infection and Infection POCT Testing Business (2019-2024)
11.8.5 PerkinElmer Recent Development
11.9 Enzo Life Sciences
11.9.1 Enzo Life Sciences Company Details
11.9.2 Enzo Life Sciences Business Overview
11.9.3 Enzo Life Sciences Infection and Infection POCT Testing Introduction
11.9.4 Enzo Life Sciences Revenue in Infection and Infection POCT Testing Business (2019-2024)
11.9.5 Enzo Life Sciences Recent Development
11.10 Abcam
11.10.1 Abcam Company Details
11.10.2 Abcam Business Overview
11.10.3 Abcam Infection and Infection POCT Testing Introduction
11.10.4 Abcam Revenue in Infection and Infection POCT Testing Business (2019-2024)
11.10.5 Abcam Recent Development
11.11 DRG International
11.11.1 DRG International Company Details
11.11.2 DRG International Business Overview
11.11.3 DRG International Infection and Infection POCT Testing Introduction
11.11.4 DRG International Revenue in Infection and Infection POCT Testing Business (2019-2024)
11.11.5 DRG International Recent Development
11.12 Creative Diagnostics
11.12.1 Creative Diagnostics Company Details
11.12.2 Creative Diagnostics Business Overview
11.12.3 Creative Diagnostics Infection and Infection POCT Testing Introduction
11.12.4 Creative Diagnostics Revenue in Infection and Infection POCT Testing Business (2019-2024)
11.12.5 Creative Diagnostics Recent Development
11.13 Beyotime
11.13.1 Beyotime Company Details
11.13.2 Beyotime Business Overview
11.13.3 Beyotime Infection and Infection POCT Testing Introduction
11.13.4 Beyotime Revenue in Infection and Infection POCT Testing Business (2019-2024)
11.13.5 Beyotime Recent Development
11.14 GenScript
11.14.1 GenScript Company Details
11.14.2 GenScript Business Overview
11.14.3 GenScript Infection and Infection POCT Testing Introduction
11.14.4 GenScript Revenue in Infection and Infection POCT Testing Business (2019-2024)
11.14.5 GenScript Recent Development
11.15 Kehua Biotech
11.15.1 Kehua Biotech Company Details
11.15.2 Kehua Biotech Business Overview
11.15.3 Kehua Biotech Infection and Infection POCT Testing Introduction
11.15.4 Kehua Biotech Revenue in Infection and Infection POCT Testing Business (2019-2024)
11.15.5 Kehua Biotech Recent Development
11.16 Mindray Medical
11.16.1 Mindray Medical Company Details
11.16.2 Mindray Medical Business Overview
11.16.3 Mindray Medical Infection and Infection POCT Testing Introduction
11.16.4 Mindray Medical Revenue in Infection and Infection POCT Testing Business (2019-2024)
11.16.5 Mindray Medical Recent Development
11.17 Antu Biotech
11.17.1 Antu Biotech Company Details
11.17.2 Antu Biotech Business Overview
11.17.3 Antu Biotech Infection and Infection POCT Testing Introduction
11.17.4 Antu Biotech Revenue in Infection and Infection POCT Testing Business (2019-2024)
11.17.5 Antu Biotech Recent Development
11.18 BD
11.18.1 BD Company Details
11.18.2 BD Business Overview
11.18.3 BD Infection and Infection POCT Testing Introduction
11.18.4 BD Revenue in Infection and Infection POCT Testing Business (2019-2024)
11.18.5 BD Recent Development
11.19 Siemens
11.19.1 Siemens Company Details
11.19.2 Siemens Business Overview
11.19.3 Siemens Infection and Infection POCT Testing Introduction
11.19.4 Siemens Revenue in Infection and Infection POCT Testing Business (2019-2024)
11.19.5 Siemens Recent Development
11.20 Qiagen
11.20.1 Qiagen Company Details
11.20.2 Qiagen Business Overview
11.20.3 Qiagen Infection and Infection POCT Testing Introduction
11.20.4 Qiagen Revenue in Infection and Infection POCT Testing Business (2019-2024)
11.20.5 Qiagen Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
 Table 1. Global Infection and Infection POCT Testing Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
 Table 2. Key Players of Equipment
 Table 3. Key Players of Test Kit
 Table 4. Key Players of Other
 Table 5. Global Infection and Infection POCT Testing Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
 Table 6. Global Infection and Infection POCT Testing Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Table 7. Global Infection and Infection POCT Testing Market Size by Region (2019-2024) & (US$ Million)
 Table 8. Global Infection and Infection POCT Testing Market Share by Region (2019-2024)
 Table 9. Global Infection and Infection POCT Testing Forecasted Market Size by Region (2025-2030) & (US$ Million)
 Table 10. Global Infection and Infection POCT Testing Market Share by Region (2025-2030)
 Table 11. Infection and Infection POCT Testing Market Trends
 Table 12. Infection and Infection POCT Testing Market Drivers
 Table 13. Infection and Infection POCT Testing Market Challenges
 Table 14. Infection and Infection POCT Testing Market Restraints
 Table 15. Global Infection and Infection POCT Testing Revenue by Players (2019-2024) & (US$ Million)
 Table 16. Global Infection and Infection POCT Testing Market Share by Players (2019-2024)
 Table 17. Global Top Infection and Infection POCT Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Infection and Infection POCT Testing as of 2023)
 Table 18. Ranking of Global Top Infection and Infection POCT Testing Companies by Revenue (US$ Million) in 2023
 Table 19. Global 5 Largest Players Market Share by Infection and Infection POCT Testing Revenue (CR5 and HHI) & (2019-2024)
 Table 20. Global Key Players of Infection and Infection POCT Testing, Headquarters and Area Served
 Table 21. Global Key Players of Infection and Infection POCT Testing, Product and Application
 Table 22. Global Key Players of Infection and Infection POCT Testing, Date of Enter into This Industry
 Table 23. Mergers & Acquisitions, Expansion Plans
 Table 24. Global Infection and Infection POCT Testing Market Size by Type (2019-2024) & (US$ Million)
 Table 25. Global Infection and Infection POCT Testing Revenue Market Share by Type (2019-2024)
 Table 26. Global Infection and Infection POCT Testing Forecasted Market Size by Type (2025-2030) & (US$ Million)
 Table 27. Global Infection and Infection POCT Testing Revenue Market Share by Type (2025-2030)
 Table 28. Global Infection and Infection POCT Testing Market Size by Application (2019-2024) & (US$ Million)
 Table 29. Global Infection and Infection POCT Testing Revenue Market Share by Application (2019-2024)
 Table 30. Global Infection and Infection POCT Testing Forecasted Market Size by Application (2025-2030) & (US$ Million)
 Table 31. Global Infection and Infection POCT Testing Revenue Market Share by Application (2025-2030)
 Table 32. North America Infection and Infection POCT Testing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 33. North America Infection and Infection POCT Testing Market Size by Country (2019-2024) & (US$ Million)
 Table 34. North America Infection and Infection POCT Testing Market Size by Country (2025-2030) & (US$ Million)
 Table 35. Europe Infection and Infection POCT Testing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 36. Europe Infection and Infection POCT Testing Market Size by Country (2019-2024) & (US$ Million)
 Table 37. Europe Infection and Infection POCT Testing Market Size by Country (2025-2030) & (US$ Million)
 Table 38. Asia-Pacific Infection and Infection POCT Testing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 39. Asia-Pacific Infection and Infection POCT Testing Market Size by Region (2019-2024) & (US$ Million)
 Table 40. Asia-Pacific Infection and Infection POCT Testing Market Size by Region (2025-2030) & (US$ Million)
 Table 41. Latin America Infection and Infection POCT Testing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 42. Latin America Infection and Infection POCT Testing Market Size by Country (2019-2024) & (US$ Million)
 Table 43. Latin America Infection and Infection POCT Testing Market Size by Country (2025-2030) & (US$ Million)
 Table 44. Middle East & Africa Infection and Infection POCT Testing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 45. Middle East & Africa Infection and Infection POCT Testing Market Size by Country (2019-2024) & (US$ Million)
 Table 46. Middle East & Africa Infection and Infection POCT Testing Market Size by Country (2025-2030) & (US$ Million)
 Table 47. SERION Immunologics Company Details
 Table 48. SERION Immunologics Business Overview
 Table 49. SERION Immunologics Infection and Infection POCT Testing Product
 Table 50. SERION Immunologics Revenue in Infection and Infection POCT Testing Business (2019-2024) & (US$ Million)
 Table 51. SERION Immunologics Recent Development
 Table 52. SD BIOSENSOR Company Details
 Table 53. SD BIOSENSOR Business Overview
 Table 54. SD BIOSENSOR Infection and Infection POCT Testing Product
 Table 55. SD BIOSENSOR Revenue in Infection and Infection POCT Testing Business (2019-2024) & (US$ Million)
 Table 56. SD BIOSENSOR Recent Development
 Table 57. Bio-Rad Laboratories Company Details
 Table 58. Bio-Rad Laboratories Business Overview
 Table 59. Bio-Rad Laboratories Infection and Infection POCT Testing Product
 Table 60. Bio-Rad Laboratories Revenue in Infection and Infection POCT Testing Business (2019-2024) & (US$ Million)
 Table 61. Bio-Rad Laboratories Recent Development
 Table 62. Thermo Fisher Scientific Company Details
 Table 63. Thermo Fisher Scientific Business Overview
 Table 64. Thermo Fisher Scientific Infection and Infection POCT Testing Product
 Table 65. Thermo Fisher Scientific Revenue in Infection and Infection POCT Testing Business (2019-2024) & (US$ Million)
 Table 66. Thermo Fisher Scientific Recent Development
 Table 67. Abbott Laboratories Company Details
 Table 68. Abbott Laboratories Business Overview
 Table 69. Abbott Laboratories Infection and Infection POCT Testing Product
 Table 70. Abbott Laboratories Revenue in Infection and Infection POCT Testing Business (2019-2024) & (US$ Million)
 Table 71. Abbott Laboratories Recent Development
 Table 72. Roche Diagnostics Company Details
 Table 73. Roche Diagnostics Business Overview
 Table 74. Roche Diagnostics Infection and Infection POCT Testing Product
 Table 75. Roche Diagnostics Revenue in Infection and Infection POCT Testing Business (2019-2024) & (US$ Million)
 Table 76. Roche Diagnostics Recent Development
 Table 77. BioMerieux Company Details
 Table 78. BioMerieux Business Overview
 Table 79. BioMerieux Infection and Infection POCT Testing Product
 Table 80. BioMerieux Revenue in Infection and Infection POCT Testing Business (2019-2024) & (US$ Million)
 Table 81. BioMerieux Recent Development
 Table 82. PerkinElmer Company Details
 Table 83. PerkinElmer Business Overview
 Table 84. PerkinElmer Infection and Infection POCT Testing Product
 Table 85. PerkinElmer Revenue in Infection and Infection POCT Testing Business (2019-2024) & (US$ Million)
 Table 86. PerkinElmer Recent Development
 Table 87. Enzo Life Sciences Company Details
 Table 88. Enzo Life Sciences Business Overview
 Table 89. Enzo Life Sciences Infection and Infection POCT Testing Product
 Table 90. Enzo Life Sciences Revenue in Infection and Infection POCT Testing Business (2019-2024) & (US$ Million)
 Table 91. Enzo Life Sciences Recent Development
 Table 92. Abcam Company Details
 Table 93. Abcam Business Overview
 Table 94. Abcam Infection and Infection POCT Testing Product
 Table 95. Abcam Revenue in Infection and Infection POCT Testing Business (2019-2024) & (US$ Million)
 Table 96. Abcam Recent Development
 Table 97. DRG International Company Details
 Table 98. DRG International Business Overview
 Table 99. DRG International Infection and Infection POCT Testing Product
 Table 100. DRG International Revenue in Infection and Infection POCT Testing Business (2019-2024) & (US$ Million)
 Table 101. DRG International Recent Development
 Table 102. Creative Diagnostics Company Details
 Table 103. Creative Diagnostics Business Overview
 Table 104. Creative Diagnostics Infection and Infection POCT Testing Product
 Table 105. Creative Diagnostics Revenue in Infection and Infection POCT Testing Business (2019-2024) & (US$ Million)
 Table 106. Creative Diagnostics Recent Development
 Table 107. Beyotime Company Details
 Table 108. Beyotime Business Overview
 Table 109. Beyotime Infection and Infection POCT Testing Product
 Table 110. Beyotime Revenue in Infection and Infection POCT Testing Business (2019-2024) & (US$ Million)
 Table 111. Beyotime Recent Development
 Table 112. GenScript Company Details
 Table 113. GenScript Business Overview
 Table 114. GenScript Infection and Infection POCT Testing Product
 Table 115. GenScript Revenue in Infection and Infection POCT Testing Business (2019-2024) & (US$ Million)
 Table 116. GenScript Recent Development
 Table 117. Kehua Biotech Company Details
 Table 118. Kehua Biotech Business Overview
 Table 119. Kehua Biotech Infection and Infection POCT Testing Product
 Table 120. Kehua Biotech Revenue in Infection and Infection POCT Testing Business (2019-2024) & (US$ Million)
 Table 121. Kehua Biotech Recent Development
 Table 122. Mindray Medical Company Details
 Table 123. Mindray Medical Business Overview
 Table 124. Mindray Medical Infection and Infection POCT Testing Product
 Table 125. Mindray Medical Revenue in Infection and Infection POCT Testing Business (2019-2024) & (US$ Million)
 Table 126. Mindray Medical Recent Development
 Table 127. Antu Biotech Company Details
 Table 128. Antu Biotech Business Overview
 Table 129. Antu Biotech Infection and Infection POCT Testing Product
 Table 130. Antu Biotech Revenue in Infection and Infection POCT Testing Business (2019-2024) & (US$ Million)
 Table 131. Antu Biotech Recent Development
 Table 132. BD Company Details
 Table 133. BD Business Overview
 Table 134. BD Infection and Infection POCT Testing Product
 Table 135. BD Revenue in Infection and Infection POCT Testing Business (2019-2024) & (US$ Million)
 Table 136. BD Recent Development
 Table 137. Siemens Company Details
 Table 138. Siemens Business Overview
 Table 139. Siemens Infection and Infection POCT Testing Product
 Table 140. Siemens Revenue in Infection and Infection POCT Testing Business (2019-2024) & (US$ Million)
 Table 141. Siemens Recent Development
 Table 142. Qiagen Company Details
 Table 143. Qiagen Business Overview
 Table 144. Qiagen Infection and Infection POCT Testing Product
 Table 145. Qiagen Revenue in Infection and Infection POCT Testing Business (2019-2024) & (US$ Million)
 Table 146. Qiagen Recent Development
 Table 147. Research Programs/Design for This Report
 Table 148. Key Data Information from Secondary Sources
 Table 149. Key Data Information from Primary Sources
 Table 150. Authors List of This Report


List of Figures
 Figure 1. Infection and Infection POCT Testing Picture
 Figure 2. Global Infection and Infection POCT Testing Market Size Comparison by Type (2024-2030) & (US$ Million)
 Figure 3. Global Infection and Infection POCT Testing Market Share by Type: 2023 VS 2030
 Figure 4. Equipment Features
 Figure 5. Test Kit Features
 Figure 6. Other Features
 Figure 7. Global Infection and Infection POCT Testing Market Size by Application (2024-2030) & (US$ Million)
 Figure 8. Global Infection and Infection POCT Testing Market Share by Application: 2023 VS 2030
 Figure 9. Hospital Case Studies
 Figure 10. Clinic Case Studies
 Figure 11. Other Case Studies
 Figure 12. Infection and Infection POCT Testing Report Years Considered
 Figure 13. Global Infection and Infection POCT Testing Market Size (US$ Million), Year-over-Year: 2019-2030
 Figure 14. Global Infection and Infection POCT Testing Market Size, (US$ Million), 2019 VS 2023 VS 2030
 Figure 15. Global Infection and Infection POCT Testing Market Share by Region: 2023 VS 2030
 Figure 16. Global Infection and Infection POCT Testing Market Share by Players in 2023
 Figure 17. Global Top Infection and Infection POCT Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Infection and Infection POCT Testing as of 2023)
 Figure 18. The Top 10 and 5 Players Market Share by Infection and Infection POCT Testing Revenue in 2023
 Figure 19. North America Infection and Infection POCT Testing Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 20. North America Infection and Infection POCT Testing Market Share by Country (2019-2030)
 Figure 21. United States Infection and Infection POCT Testing Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 22. Canada Infection and Infection POCT Testing Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 23. Europe Infection and Infection POCT Testing Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 24. Europe Infection and Infection POCT Testing Market Share by Country (2019-2030)
 Figure 25. Germany Infection and Infection POCT Testing Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 26. France Infection and Infection POCT Testing Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 27. U.K. Infection and Infection POCT Testing Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 28. Italy Infection and Infection POCT Testing Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 29. Russia Infection and Infection POCT Testing Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 30. Nordic Countries Infection and Infection POCT Testing Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 31. Asia-Pacific Infection and Infection POCT Testing Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 32. Asia-Pacific Infection and Infection POCT Testing Market Share by Region (2019-2030)
 Figure 33. China Infection and Infection POCT Testing Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 34. Japan Infection and Infection POCT Testing Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 35. South Korea Infection and Infection POCT Testing Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 36. Southeast Asia Infection and Infection POCT Testing Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 37. India Infection and Infection POCT Testing Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 38. Australia Infection and Infection POCT Testing Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 39. Latin America Infection and Infection POCT Testing Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 40. Latin America Infection and Infection POCT Testing Market Share by Country (2019-2030)
 Figure 41. Mexico Infection and Infection POCT Testing Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 42. Brazil Infection and Infection POCT Testing Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 43. Middle East & Africa Infection and Infection POCT Testing Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 44. Middle East & Africa Infection and Infection POCT Testing Market Share by Country (2019-2030)
 Figure 45. Turkey Infection and Infection POCT Testing Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 46. Saudi Arabia Infection and Infection POCT Testing Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 47. UAE Infection and Infection POCT Testing Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 48. SERION Immunologics Revenue Growth Rate in Infection and Infection POCT Testing Business (2019-2024)
 Figure 49. SD BIOSENSOR Revenue Growth Rate in Infection and Infection POCT Testing Business (2019-2024)
 Figure 50. Bio-Rad Laboratories Revenue Growth Rate in Infection and Infection POCT Testing Business (2019-2024)
 Figure 51. Thermo Fisher Scientific Revenue Growth Rate in Infection and Infection POCT Testing Business (2019-2024)
 Figure 52. Abbott Laboratories Revenue Growth Rate in Infection and Infection POCT Testing Business (2019-2024)
 Figure 53. Roche Diagnostics Revenue Growth Rate in Infection and Infection POCT Testing Business (2019-2024)
 Figure 54. BioMerieux Revenue Growth Rate in Infection and Infection POCT Testing Business (2019-2024)
 Figure 55. PerkinElmer Revenue Growth Rate in Infection and Infection POCT Testing Business (2019-2024)
 Figure 56. Enzo Life Sciences Revenue Growth Rate in Infection and Infection POCT Testing Business (2019-2024)
 Figure 57. Abcam Revenue Growth Rate in Infection and Infection POCT Testing Business (2019-2024)
 Figure 58. DRG International Revenue Growth Rate in Infection and Infection POCT Testing Business (2019-2024)
 Figure 59. Creative Diagnostics Revenue Growth Rate in Infection and Infection POCT Testing Business (2019-2024)
 Figure 60. Beyotime Revenue Growth Rate in Infection and Infection POCT Testing Business (2019-2024)
 Figure 61. GenScript Revenue Growth Rate in Infection and Infection POCT Testing Business (2019-2024)
 Figure 62. Kehua Biotech Revenue Growth Rate in Infection and Infection POCT Testing Business (2019-2024)
 Figure 63. Mindray Medical Revenue Growth Rate in Infection and Infection POCT Testing Business (2019-2024)
 Figure 64. Antu Biotech Revenue Growth Rate in Infection and Infection POCT Testing Business (2019-2024)
 Figure 65. BD Revenue Growth Rate in Infection and Infection POCT Testing Business (2019-2024)
 Figure 66. Siemens Revenue Growth Rate in Infection and Infection POCT Testing Business (2019-2024)
 Figure 67. Qiagen Revenue Growth Rate in Infection and Infection POCT Testing Business (2019-2024)
 Figure 68. Bottom-up and Top-down Approaches for This Report
 Figure 69. Data Triangulation
 Figure 70. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

SecuX Technology Inc